Bite Acquisition Corp. financial data

Location
Chicago, IL
Fiscal year end
31 December
Latest financial report
10-Q - Q1 2024 - 21 May 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3% % -84%
Debt-to-equity -105% % 39%
Return On Equity 7% %
Return On Assets -1% % -318%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7,999,298 shares
Common Stock, Shares, Outstanding 5,640,000 shares
Common Stock, Value, Issued $564 USD
Weighted Average Number of Shares Outstanding, Basic 5,640,000 shares 0%
Weighted Average Number of Shares Outstanding, Diluted 5,640,000 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) $2,663,379 USD -39%
Nonoperating Income (Expense) $2,989,149 USD 2.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $325,770 USD -67%
Income Tax Expense (Benefit) $589,625 USD 208%
Net Income (Loss) Attributable to Parent $263,855 USD -155%
Earnings Per Share, Basic 0 USD/shares 50%
Earnings Per Share, Diluted 0 USD/shares 50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $4,281 USD -89%
Assets, Current $147,152 USD -34%
Assets $25,606,869 USD -17%
Liabilities, Current $3,939,544 USD 68%
Deferred Income Tax Liabilities, Net $435,316 USD 353%
Liabilities $4,394,110 USD 79%
Retained Earnings (Accumulated Deficit) $5,431,007 USD -5.1%
Stockholders' Equity Attributable to Parent $4,258,776 USD -140%
Liabilities and Equity $25,606,869 USD -17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $589,161 USD -116%
Net Cash Provided by (Used in) Financing Activities $5,109,425 USD -1073%
Net Cash Provided by (Used in) Investing Activities $5,701,920 USD
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 5,640,000 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,334 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4,281 USD -89%
Deferred Income Tax Expense (Benefit) $77,674 USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Additional Paid in Capital $1,171,667 USD -65%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%